Lipella Pharmaceuticals Inc.

04/09/2025 | Press release | Distributed by Public on 04/09/2025 15:07

Amendments to Bylaws (Form 8-K)

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On April 8, 2025, the Company filed a Certificate of Amendment of Certificate of Designation of Preferences, Rights and Limitations of Series C Voting Convertible Preferred Stock (the "Series C Certificate of Amendment") with the Secretary of State of the State of Delaware. The Series C Certificate of Amendment amended the Certificate of Designation of Preferences, Rights and Limitations of Series C Voting Convertible Preferred Stock of the Company (the "Certificate of Designation") to increase the number of shares of the Company's Series C Voting Convertible Preferred Stock, par value $0.0001 per share, designated pursuant to the Certificate of Designation from 1,050,000 shares to 1,260,000 shares.

The foregoing description of the Series C Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Series C Certificate of Amendment, a copy of which is filed hereto as Exhibit 3.1 and incorporated herein by reference.

Lipella Pharmaceuticals Inc. published this content on April 09, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on April 09, 2025 at 21:07 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]